학술논문

Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial
Document Type
Article
Source
In Blood 5 October 2023 142(14):1208-1218
Subject
Clinical Trials and Observations
Lymphoid Neoplasia
Free Research Articles
Language
ISSN
0006-4971